Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isoeffect lines using TDF and CRE concepts.

S J Supe, J B Sasane, M K Gupta

    Clinical Radiology
    |May 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First results from testing of the full ITER hard x-ray monitor prototype on the ADITYA Upgrade tokamak.

    The Review of scientific instruments·2026
    Same author

    Aerogel as a sustainable lightweight material: A comprehensive review of synthesis, properties, and applications.

    International journal of biological macromolecules·2025
    Same author

    A critical review on the properties and applications of bulk micro and nanobubbles for the degradation of organic pollutants in wastewater treatment.

    The Science of the total environment·2025
    Same author

    PLA based biodegradable bionanocomposite filaments reinforced with nanocellulose: development and analysis of properties.

    Scientific reports·2024
    Same author

    Extraction of nano-crystalline cellulose for development of aerogel: Structural, morphological and antibacterial analysis.

    Heliyon·2024
    Same author

    Author Correction: Role of pinch in Argon impurity transport in ohmic discharges of Aditya-U Tokamak.

    Scientific reports·2023

    Isoeffect lines derived from time-dose factors (TDFs) and clinical radiobiological effectiveness (CRE) concepts do not always match physical isodose lines in radiotherapy. This discrepancy impacts treatment planning for various cancers, including bladder and cervical cancer.

    Area of Science:

    • Radiation Oncology
    • Medical Physics
    • Cancer Treatment Planning

    Background:

    • Radiotherapy treatment planning commonly relies on isodose lines.
    • Isoeffect lines, based on time-dose factors (TDFs) and clinical radiobiological effectiveness (CRE), are also utilized.
    • The congruence of these different line types in treatment planning is not fully established.

    Purpose of the Study:

    • To determine if isoeffect lines derived from TDFs and CRE concepts are identical to physical isodose lines across various radiotherapy scenarios.
    • To investigate the influence of treatment modality on isoeffect line characteristics.
    • To explore the impact of variations in empirical relationship exponents for normalized source dose (NSD) on isoeffect lines.

    Main Methods:

    • Generation and comparison of isoeffect lines using TDF and CRE concepts for specific treatment schedules.

    Related Experiment Videos

  • Analysis of treatment plans for bladder cancer, uterine cervix cancer (combined and intracavitary therapy alone).
  • Investigation of the effect of treatment mode and variations in NSD exponents on isoeffect line patterns.

    • Main Results:

    • Isoeffect lines derived from TDF and CRE concepts were found to be non-identical to physical isodose curves in several treatment situations.
    • Treatment planning outcomes based on these differing isoeffect lines will not be precisely the same.
    • The study explored the dependence of isoeffect lines on variations in time and fraction exponents within empirical NSD relationships.

    Conclusions:

    • Physical isodose lines and isoeffect lines (TDF/CRE) are not universally equivalent in radiotherapy planning.
    • Discrepancies necessitate careful consideration in treatment plan development to ensure optimal outcomes.
    • Clinical trials for bladder and cervical cancer are underway, utilizing both isodose curves and CRE/TDF-based isoeffect lines.